Pteridines useful as hcv inhibitors and methods for the...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 475/10 (2006.01) A61K 31/519 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2608326

The present invention relates to the use of pteridines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to compounds per se and their use as medicines. The present invention also concerns processes for the preparation of such compounds, pharmaceutical compositions comprising them, and combinations of said compounds with other anti-HCV agents.

La présente invention concerne l'utilisation de pteridines comme inhibiteurs de la réplication du VHC et leur utilisation dans des compositions pharmaceutiques destinées à traiter ou à combattre des infections par le VHC. Par ailleurs, cette invention concerne des composés en tant que tels et leur utilisation comme produits médicinaux. Cette invention concerne aussi des processus de préparation de ces composés, des compositions pharmaceutiques comprenant ces composés et des combinaisons de ces composés avec d'autres agents anti-VHC.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pteridines useful as hcv inhibitors and methods for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pteridines useful as hcv inhibitors and methods for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pteridines useful as hcv inhibitors and methods for the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1592422

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.